Jeff Bezos has signed on one of the world’s top scientists to help him pursue his new anti-aging technology. The Amazon founder’s latest project, known as Altos Labs, has drafted Hal Barron to join the company as its chief executive.
Barron was formerly the chief scientific officer for the British pharmaceutical company GlaxoSmithKline. The company also drew $3 billion in funding on Wednesday alongside the new addition to their team.
Altos and its prestigious lineup of doctors and scientists plan to pursue the nature of aging by reprogramming living cells.